Key Finding
Early dual antiplatelet therapy initiated within 6 hours of moderate ischaemic stroke onset, combined with intravenous thrombolysis, increased the rate of excellent functional outcomes at 90 days from 62.0% to 68.7% without significantly increasing symptomatic intracranial haemorrhage risk.
Researchers in China studied whether adding two antiplatelet medications (aspirin and ticagrelor) immediately after stroke could improve recovery in patients receiving standard clot-busting treatment. The study involved 1,382 stroke patients across 60 hospitals who received either the dual antiplatelet therapy or placebo within 6 hours of stroke onset, alongside intravenous thrombolysis. After 90 days, nearly 69% of patients receiving the combination therapy achieved excellent functional recovery (minimal or no disability) compared to 62% in the placebo group—a statistically significant improvement. The bleeding risk, a major concern with antiplatelet drugs, was similar between groups, though the study couldn't completely rule out a small increased risk.
What does this mean for acupuncture patients? While this study focused on pharmaceutical interventions for acute stroke, acupuncture is increasingly recognized as a complementary therapy during stroke rehabilitation. Many patients incorporate acupuncture into their recovery program after the acute phase to support neurological function, improve motor skills, reduce spasticity, and enhance overall functional outcomes. The timing and approach differ significantly—this study examined immediate drug intervention during emergency stroke treatment, while acupuncture typically becomes part of rehabilitation care. Patients who have experienced stroke should discuss integrative treatment options with their healthcare team, as acupuncture may complement conventional therapies during recovery. If considering acupuncture for stroke rehabilitation or prevention of recurrence, seek a licensed acupuncturist experienced in neurological conditions and stroke care.
This multicentre, double-blind RCT (n=1,382) evaluated early dual antiplatelet therapy (DAPT: aspirin plus ticagrelor) initiated within 6 hours of ischaemic stroke onset as adjunct to intravenous thrombolysis. Inclusion criteria: NIHSS 4-10 (moderate stroke). Primary efficacy outcome: modified Rankin Scale 0-1 at 90 days occurred in 68.7% (DAPT) versus 62.0% (placebo); risk ratio 1.11 (95% CI 1.03-1.20; p=0.0089), representing an absolute risk difference of 6.7%. Primary safety outcome: symptomatic intracranial haemorrhage within 36 hours showed no significant difference (0.9% vs 0.7%; RR 1.20, 95% CI 0.37-3.93; p=0.76), though wide confidence intervals indicate uncertainty. Clinical takeaway: Early DAPT improves functional outcomes when added to thrombolysis in moderate ischaemic stroke without clearly increased bleeding risk, though safety margins remain incompletely defined. This pharmaceutical study has limited direct implications for acupuncture practice but confirms timing-dependent neurological recovery patterns relevant to rehabilitation planning.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.